Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells

被引:34
|
作者
Blume, Lawrence C. [1 ]
Eldeeb, Khalil [1 ]
Bass, Caroline E. [1 ]
Selley, Dana E. [2 ]
Howlett, Allyn C. [1 ]
机构
[1] Wake Forest Univ Hlth Sci, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA
[2] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
关键词
CB1; receptor; CRIP1a; cAMP; ERK1/2; G protein; Endocannabinoid; ADENYLATE-CYCLASE; TYROSINE KINASES; INVERSE AGONIST; BRAIN; TRANSDUCTION; PHARMACOLOGY; ASSOCIATION; ENDOCYTOSIS; INHIBITION; ACTIVATION;
D O I
10.1016/j.cellsig.2014.11.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CBI cannabinoid receptors (CB1R) are one of the most abundantly expressed G protein coupled receptors (GPCR) in the CNS and regulate diverse neuronal functions. The identification of GPCR interacting proteins has provided additional insight into the fine-tuning and regulation of numerous GPCRs. The cannabinoid receptor interacting protein 1a (CRIP1a) binds to the distal carboxy terminus of CB1R, and has been shown to alter CB1R-mediated neuronal function [1]. The mechanisms by which CRIP1a regulates CB1R activity have not yet been identified; therefore the focus of this investigation is to examine the cellular effects of CRIP1a on CB1R signaling using neuronal N18TG2 cells stably transfected with CRIP1a over-expressing and CRIP1a knockdown constructs. Modulation of endogenous CRIP1 a expression did not alter total levels of CB1R, ERK, or forskolin-activated adenylyl cyclase activity. When compared to WT cells, CRIP1a over-expression reduced basal phosphoERK levels, whereas depletion of CRIP1a augmented basal phosphoERK levels. Stimulation of phosphoERK by the CB1R agonists WIN55212-2, CP55940 or methanandamide was unaltered in CRIP1a over-expressing clones compared with WT. However, CRIP1 a knockdown clones exhibited enhanced ERIC phosphorylation efficacy in response to CP55940. In addition, CRIP1a knockdown clones displayed a leftward shift in CP55940-mediated inhibition of forskolin-stimulated cAMP accumulation. CB1R-mediated G(i3) and G(o) activation by CP99540 was attenuated by CRIP1a over-expression, but robustly enhanced in cells depleted of CRIP1a. Conversely, CP55940-mediated and G(i2) activation was significant enhanced in cells over-expressing CRIP1a, but not in cells deficient of CRIP1a. These studies suggest a mechanism by which endogenous levels of CRIP1a modulate CB1R-mediated signal transduction by facilitating a G(i/o) protein subtype preference for G(i1) and G(i2), accompanied by an overall suppression of G-protein-mediated signaling in neuronal cells. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:716 / 726
页数:11
相关论文
共 50 条
  • [1] Cannabinoid receptor-interacting protein Crip1a modulates CB1 receptor signaling in mouse hippocampus
    Guggenhuber, Stephan
    Alpar, Alan
    Chen, Rongqing
    Schmitz, Nina
    Wickert, Melanie
    Mattheus, Tobias
    Harasta, Anne E.
    Purrio, Martin
    Kaiser, Nadine
    Elphick, Maurice R.
    Monory, Krisztina
    Kilb, Werner
    Luhmann, Heiko J.
    Harkany, Tibor
    Lutz, Beat
    Klugmann, Matthias
    BRAIN STRUCTURE & FUNCTION, 2016, 221 (04) : 2061 - 2074
  • [2] Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure
    Booth, William T.
    Walker, Noah B.
    Lowther, W. Todd
    Howlett, Allyn C.
    MOLECULES, 2019, 24 (20):
  • [3] Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b)
    Singh, Pratishtha
    Ganjiwale, Anjali
    Howlet, Allyn C.
    Cowsik, Sudha M.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2019, 59 (12) : 5294 - 5303
  • [4] Approaches to Assess Biased Signaling at the CB1R Receptor
    Laprairie, Robert B.
    Stahl, Edward L.
    Bohn, Laura M.
    CANNABINOIDS AND THEIR RECEPTORS, 2017, 593 : 259 - 279
  • [5] In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b)-CB1 cannabinoid receptor
    Singh, Pratishtha
    Ganjiwale, Anjali
    Howlett, Allyn C.
    Cowsik, Sudha M.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2017, 77 : 311 - 321
  • [6] Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
    Fletcher-Jones, Alexandra
    Hildick, Keri L.
    Evans, Ashley J.
    Nakamura, Yasuko
    Henley, Jeremy M.
    Wilkinson, Kevin A.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2020, 13
  • [7] Cannabinoid Receptor-Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation
    Smith, Tricia H.
    Blume, Lawrence C.
    Straiker, Alex
    Cox, Jordan O.
    David, Bethany G.
    Mcvoy, Julie R. Secor
    Sayers, Katherine W.
    Poklis, Justin L.
    Abdullah, Rehab A.
    Egertova, Michaela
    Chen, Ching-Kang
    Mackie, Ken
    Elphick, Maurice R.
    Howlett, Allyn C.
    Selley, Dana E.
    MOLECULAR PHARMACOLOGY, 2015, 87 (04) : 747 - 765
  • [8] Differential Expression of CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Protein 1a in Labor
    Kozakiewicz, Melissa L.
    Zhang, Jie
    Leone-Kabler, Sandra
    Yamaleyeva, Liliya M.
    McDonald, Anna G.
    Brost, Brian C.
    Howlett, Allyn C.
    CANNABIS AND CANNABINOID RESEARCH, 2022, 7 (03) : 279 - 288
  • [9] Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1
    Petgrave, Maya
    Ramgoolam, Shubham Devesh
    Ganesan, Aravindhan
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2023, 64 (02) : 499 - 517
  • [10] Clinical Importance of Cannabinoid Type 1 Receptor (CB1R) and Cannabinoid Type 2 Receptor (CB2R) Expression in Renal Cell Carcinoma
    Deligiannis, Dimitrios
    Anastasiou, Ioannis
    Mitropoulos, Dionysios
    Mitsos, Panagiotis
    Theocharis, Stamatios
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)